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Abstract
Background: Even though real-time PCR has been broadly applied in biomedical sciences, data
processing procedures for the analysis of quantitative real-time PCR are still lacking; specifically in
the realm of appropriate statistical treatment. Confidence interval and statistical significance
considerations are not explicit in many of the current data analysis approaches. Based on the
standard curve method and other useful data analysis methods, we present and compare four
statistical approaches and models for the analysis of real-time PCR data.
Results: In the first approach, a multiple regression analysis model was developed to derive ∆∆Ct
from estimation of interaction of gene and treatment effects. In the second approach, an ANCOVA
(analysis of covariance) model was proposed, and the ∆∆Ct can be derived from analysis of effects
of variables. The other two models involve calculation ∆Ct followed by a two group t-test and non-
parametric analogous Wilcoxon test. SAS programs were developed for all four models and data
output for analysis of a sample set are presented. In addition, a data quality control model was
developed and implemented using SAS.
Conclusion: Practical statistical solutions with SAS programs were developed for real-time PCR
data and a sample dataset was analyzed with the SAS programs. The analysis using the various
models and programs yielded similar results. Data quality control and analysis procedures
presented here provide statistical elements for the estimation of the relative expression of genes
using real-time PCR.
Background
Real-time PCR is one of the most sensitive and reliably
quantitative methods for gene expression analysis. It has
been broadly applied to microarray verification, pathogen
quantification, cancer quantification, transgenic copy
number determination and drug therapy studies [1-4]. A
PCR has three phases, exponential phase, linear phase and
plateau phase as shown in Figure 1. The exponential
phase is the earliest segment in the PCR, in which product
increases exponentially since the reagents are not limited.
The linear phase is characterized by a linear increase in
product as PCR reagents become limited. The PCR will
eventually reach the plateau phase during later cycles and
the amount of product will not change because some rea-
gents become depleted. Real-time PCR exploits the fact
that the quantity of PCR products in exponential phase is
in proportion to the quantity of initial template under
ideal conditions [5,6]. During the exponential phase PCR
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product will ideally double during each cycle if efficiency
is perfect, i.e. 100%. It is possible to make the PCR ampli-
fication efficiency close to 100% in the exponential
phases if the PCR conditions, primer characteristics, tem-
plate purity, and amplicon lengths are optimal.
Both genomic DNA and reverse transcribed cDNA can be
used as templates for real-time PCR. The dynamics of PCR
are typically observed through DNA binding dyes like
SYBR green or DNA hybridization probes such as molecu-
lar beacons (Strategene) or Taqman probes (Applied Bio-
systems) [2]. The basis of real-time PCR is a direct positive
association between a dye with the number of amplicons.
As shown in Figure (1B and 1C), the plot of logarithm 2-
based transformed fluorescence signal versus cycle
number will yield a linear range at which logarithm of flu-
orescence signal correlates with the original template
amount. A baseline and a threshold can then be set for fur-
ther analysis. The cycle number at the threshold level of
log-based fluorescence is defined as Ct number, which is
the observed value in most real-time PCR experiments,
and therefore the primary statistical metric of interest.
Real-time PCR data are quantified absolutely and rela-
tively. Absolute quantification employs an internal or
external calibration curve to derive the input template
copy number. Absolute quantification is important in
case that the exact transcript copy number needs to be
determined, however, relative quantification is sufficient
for most physiological and pathological studies. Relative
quantification relies on the comparison between expres-
sion of a target gene versus a reference gene and the
expression of same gene in target sample versus reference
samples [7].
Since relative quantification is the goal for most for real-
time PCR experiments, several data analysis procedures
have been developed. Two mathematical models are very
widely applied: the efficiency calibrated model [7,8] and
the ∆∆Ct model [9]. The experimental systems for both
models are similar. The experiment will involve a control
sample and a treatment sample. For each sample, a target
gene and a reference gene for internal control are included
for PCR amplification from serially diluted aliquots. Typ-
ically several replicates are used for each diluted concen-
tration to derive amplification efficiency. PCR
amplification efficiency can be either defined as percent-
age (from 0 to 1) or as time of PCR product increase per
cycle (from 1 to 2). Unless specified as percentage ampli-
fication efficiency (PE), we refer the amplification effi-
ciency (E) to PCR product increase (1 to 2) in this article.
The efficiency-calibrated model is a more generalized
∆∆Ct model. Ct number is first plotted against cDNA
input (or logarithm cDNA input), and the slope of the
plot is calculated to determine the amplification efficiency
Real-time PCR Figure 1
Real-time PCR. (A) Theoretical plot of PCR cycle number 
against PCR product amount is depicted. Three phases can 
be observed for PCRs: exponential phase, linear phase and 
plateau phase. (B) shows a theoretical plot of PCR cycle 
number against logarithm PCR product amount. Panel (C) is 
the output of a serial dilution experiment from an ABI 7000 
real-time PCR instrument.
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(E). ∆Ct for each gene (target or reference) is then calcu-
lated by subtracting the Ct number of target sample from
that of control sample. As shown in Equation 1, the ratio
of target gene expression in treatment versus control can
be derived from the ratio between target gene efficiency
(Etarget) to the power of target ∆Ct (∆Cttarget) and reference
gene efficiency (Ereference) to the power of reference ∆Ct
(∆Ctreference). The ∆∆Ct model can be derived from the effi-
ciency-calibrated model, if both target and reference genes
reach their highest PCR amplification efficiency. In this
circumstance, both target efficiency (Etarget) and control
efficiency (Econtrol) equals 2, indicating amplicon dou-
bling during each cycle, then there would be the same
expression ratio derived from 2-∆∆Ct [7,9].
Whereas ∆Cttarget = Ctcontrol - Cttreatment and ∆Ctreference = Ctcon-
trol - Cttreatment
Ratio = 2-∆∆Ct   Equation 2
Whereas ∆∆Ct = ∆Ctreference - ∆Cttarget
Even though both the efficiency-calibrated and ∆∆Ct
models are widely applied in gene expression studies, not
many papers have thorough discussions of the statistical
considerations in the analysis of the effect of each experi-
mental factor as well as significance testing. One of the
few studies that employed substantial statistical analysis
used the REST® program [8]. The software presented in this
article is based on the efficiency-calibrated model and
employed randomization tests to obtain the significance
level. However, the article did not provide a detailed
model for the effects of different experimental factors
involved. Another statistical study of real-time PCR data
used a simple linear regression model to estimate the ratio
through Ct calculation [10]. However, the logarithm-
based fluorescence was used as the dependent variable in
the model, which we believe does not adequately reflect
the nature of real-time PCR data. It follows that Ct should
be the dependent variable for statistical analysis, because
it is the outcome value directly influenced by treatment,
concentration and sample effects. Both studies used the
efficiency-calibrated models. Despite the publication of
these two methods, many research articles published with
real-time PCR data actually do not present P values and
confidence intervals [11-13]. We believe that these statis-
tics are desirable to facilitate robust interpretation of the
data.
A priori, we consider the confidence interval and P value of
∆∆Ct data to be very important because these directly
influence the interpretation of ratio. Without a proper sta-
tistical modeling and analysis, the interpretation of real-
time PCR data may lead the researcher to false positive
conclusions, which is especially potentially troublesome
in clinical applications. We hereby developed four statis-
tical methodologies for processing real-time PCR data
using a modified ∆∆Ct method. The statistical methodol-
ogies can be adapted to other mathematical models with
modifications. SAS programs implementing the method-
ologies and data control are presented with real-time PCR
practitioners in mind for turnkey data analysis. Standard
deviations, confidence levels and P values are presented
directly from the SAS output. We also included analysis of
the sample data set and SAS programs for the analysis in
the online supplementary materials.
Results and discussion
Data quality control
From the two mathematical models for relative quantifi-
cation of real-time PCR data, we observe disparities
between data quality standards. For efficiency-calibrated
method, the author who described this procedure [7]
assumed that the amplification efficiency for each gene
(target and reference) is the same among different experi-
mental samples (treatment and control). In contrast,
whereas an amplification efficiency of 2 is not required,
the ∆∆Ct method is more stringent by assuming that all
reactions should reach an amplification efficiency of 2. In
other words, the amount of product should double during
each cycle [9]. Moreover, the ∆∆Ct method assumes that
the PCR amplification efficiency for each sample will be 2,
if PCRs for one set of the samples reaches full amplifica-
tion efficiency. However, this assumption neglects the
effect of different cDNA samples.
Data quality could be examined through a correlation
model. Even though examining the correlation between
Ct number and concentration can provide an effective
quality control, a better approach might be to examine the
correlation between Ct and the logarithm (base 2) trans-
formed concentration of template, which should yield a
significant simple linear relationship for each gene and
sample combination. For example, for a target gene in the
control sample, the Ct number should correlate with the
logarithm transformed concentration following the sim-
ple linear regression model in equation 3. In the equation,
Xlcon represents the logarithm transformed concentration,
β0 represents the intercept of the regression line, and βcon
represents the slope of the regression line [14]. The accept-
able real-time PCR data should have two features from the
regression analysis. First, the slope should not be signifi-
cantly different from -1. Second, the slopes for all four
combinations of genes and samples as shown in Table 1
should not be significantly different from one another. A
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SAS program was developed to perform the data quality
control in Program1_QC.sas (additional file 1).
Ct = β0 + βconXlcon + ε   Equation 3
The input data is grouped as shown in Table 1 and addi-
tional file 2. Each combination of gene and sample was
classified in one group named from 1 to 4. The SAS proce-
dure Proc Mixed was used for performing simple linear
Table 1: The sample real-time PCR data for analysis. In this data set, there two types of samples (treatment and control); two genes 
(reference and target); and four concentrations of each combination of gene and sample. For data quality control and ANCOVA 
analysis, the real-time PCR sample data set can be grouped in four groups according to the combination of sample and gene. The 
Control-Target combination effect was named group 1, Treatment-Target group 2, Control-Reference group 3 and Treatment-
Reference group 4.
Replicate Sample Gene Concentration Ct Group (Class)
1 Control Target 10 23.1102 1
2 Control Target 10 22.9003 1
3 Control Target 10 22.8972 1
1C o n t r o l T a r g e t 22 6 . 5 8 0 11
2C o n t r o l T a r g e t 22 6 . 2 1 3 91
3C o n t r o l T a r g e t 22 6 . 0 6 0 61
1 Control Target 0.4 28.1125 1
2 Control Target 0.4 28.1899 1
3 Control Target 0.4 27.5949 1
1 Control Target 0.08 30.2772 1
2 Control Target 0.08 30.4667 1
3 Control Target 0.08 30.7571 1
1 Treatment Target 10 21.7813 2
2 Treatment Target 10 21.7564 2
3 Treatment Target 10 21.641 2
1 Treatment Target 2 23.7965 2
2 Treatment Target 2 23.7571 2
3 Treatment Target 2 23.724 2
1 Treatment Target 0.4 26.3794 2
2 Treatment Target 0.4 26.2542 2
3 Treatment Target 0.4 25.9621 2
1 Treatment Target 0.08 28.5479 2
2 Treatment Target 0.08 28.3894 2
3 Treatment Target 0.08 28.3416 2
1C o n t r o l R e f e r e n c e 1 0 1 9 . 7 4 1 53
2C o n t r o l R e f e r e n c e 1 01 9 . 4 9 4 3
3C o n t r o l R e f e r e n c e 1 0 1 9 . 3 9 0 63
1 Control Reference 2 21.9838 3
2 Control Reference 2 22.4435 3
3C o n t r o l R e f e r e n c e 2 2 2 . 5 7 3
1 Control Reference 0.4 24.8109 3
2 Control Reference 0.4 24.4327 3
3 Control Reference 0.4 24.2342 3
1 Control Reference 0.08 26.7319 3
2 Control Reference 0.08 26.8206 3
3C o n t r o l R e f e r e n c e 0 . 0 8 2 6 . 8 2 2 3
1 Treatment Reference 10 18.4468 4
2 Treatment Reference 10 18.8227 4
3 Treatment Reference 10 18.3061 4
1 Treatment Reference 2 21.2568 4
2 Treatment Reference 2 21.0956 4
3 Treatment Reference 2 20.8473 4
1 Treatment Reference 0.4 23.2322 4
2 Treatment Reference 0.4 22.9577 4
3 Treatment Reference 0.4 23.2415 4
1 Treatment Reference 0.08 25.4817 4
2 Treatment Reference 0.08 25.608 4
3 Treatment Reference 0.08 25.5675 4BMC Bioinformatics 2006, 7:85 http://www.biomedcentral.com/1471-2105/7/85
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regression for each group based on the model described
above. The 95% confidence levels for slopes were esti-
mated, which are expected not be significantly different
from -1. The abbreviated SAS output for the analysis of a
sample data set is presented in SASOutput.doc (additional
file 3). Slopes for Ct and logarithm transformed concen-
trations for all four groups were not significantly different
from -1 based on 95% confidence level. In addition to the
numeric output, the program also provides a visualization
of data quality as shown in Figure 2, where the Ct number
is plotted against logarithm transformed template con-
centration. A simple linear relationship should be
observed between the Ct number and logarithm trans-
formed concentration.
Multiple regression model
Several effects need to be taken in to consideration in the
∆∆Ct method, namely, the effect of treatment, gene, con-
centration, and replicates. If we consider these effects as
quantitative variables and have the Ct number relating to
these multiple effects and their interactions, we can
develop a multiple regression model as follows in Equa-
tion 4.
Ct = β0 + βconXicon + βtreatXitreat + βgeneXigene + βcontreatXiconXitreat
+  βcongeneXiconXigene  +  βgenetreatXigeneXitreat  +  βcongenetreatXiconX-
itreatXigene + ε   Equation 4
In this model, Ct is the true dependent, the β0 is the inter-
cept, βxs are the regression coefficients for the correspond-
ing X (independent) terms, and ε is the error term [14].
Data quality control Figure 2
Data quality control. The four classes represent four different combinations of sample and gene, which are reference gene 
in control sample, target gene in control sample, reference gene in treatment sample, and target gene in treatment sample. 
Each class should derive a linear correlation between Ct and logarithm transformed concentration pf PCR product with a slope 
of -1.BMC Bioinformatics 2006, 7:85 http://www.biomedcentral.com/1471-2105/7/85
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The model considers the effect of concentration, treat-
ment, gene and their interactions. We are principally
interested in the interaction between gene and treatment,
which addresses the degree of the Ct differences between
target gene and reference gene in treated vs. control sam-
ples: i.e., ∆∆Ct. ∆∆Ct can therefore be estimated from the
different combinations values of βgenetreat. The four groups
in Table 1 also represent the options of combinational
effects of treatment and gene. The goal is to statistically
test for differences between target and reference genes in
treatment vs. control samples. Therefore, the null hypoth-
esis is the Ct differences between target and reference
genes will be the same in treatment vs control samples,
which can be represented by combinational effect (CE) as:
CE1-CE3 = CE2-CE4. An alternative formula will be: CE1-
CE2-CE3+CE4 = 0, which will yield an estimation of
∆∆Ct. If the null hypothesis is not rejected, then the ∆∆Ct
would not be significantly different from 0, otherwise, the
∆∆Ct can be derived from the estimation of the test. In this
way, we can perform a test of different combinational
effects of βgenetreat and estimate the ∆∆Ct from it. As shown
in the ∆∆Ct formula in Equation 2, if a ∆∆Ct is equal to 0,
the ratio will be 1, which indicates no change in gene
expression between control and treatment.
A SAS program for multiple regression model
SAS procedure PROC GLM was used for ∆∆Ct estimation
in Program2_MR.sas in additional file 4. The multiple
regression model is stated in a model statement. The com-
binational effect of gene and treatment are evaluated in
the estimate and contrast statement. The null hypothesis
of CE1-CE2-CE3+CE4 = 0 is tested in the contrast state-
ment and the parameter estimation yield the ∆∆Ct value.
The SAS input file is available in additional file 5 and the
SAS output for the multiple regression is in SASOut-
put.doc (additional file 3).
The SAS output gives a very comprehensive analysis of the
data. We are interested in two aspects of the analysis. First,
we want to test whether the ∆∆Ct value is significantly dif-
ferent from 0 at P = 0.05. If the ∆∆Ct is not significantly
different from 0, then we conclude the treatment does not
have a significant effect on target gene expression; other-
wise, the inverse is concluded. If the effect is significant,
we are interested in the standard deviation of ∆∆Ct value,
from which we can derive the ratio of gene expression as
discussed later. The SAS output provides the point estima-
tion (-0.6848) and standard error (-0.1185) for the ∆∆Ct.
PROC GLM or PROC MIXED are interchangeable in this
application. If the experiments involve multiple biologi-
cal replicates, replicate effect can also be considered
through modifying the SAS program. Then the estimation
will be the combined effect of gene, treatment and repli-
cate.
Analysis of covariance and SAS code
Another way to approach the real-time PCR data analysis
is by using an analysis of covariance (ANCOVA). A simpli-
fied model can be derived from transforming the data into
a grouped data as shown in Table 1 and additional file 2
resulting in Equation 5.
Ct  =  β0 +  βconXicon +  βgroupXigroup +  βgroupconXigroupXicon +  ε.
Equation 5
We are interested in two questions here. First, are the cov-
ariance adjusted averages among the four groups equal?
Second, what is the Ct difference of target gene value
between treatment and control sample after corrected by
reference gene? In this case, the null hypothesis will be
(µ2-µ1)-(µ4-µ3) = 0, and the test will yield a parameter
estimation of ∆∆Ct as shown in the
Program3_ANCOVA.sas (additional file 6).
The SAS code implementing the ANCOVA model is simi-
lar to that of multiple regression model. Either SAS proce-
dures PROC GLM or PROC MIXED can be employed to
implement the ANCOVA model; and we used PROC
MIXED here. The class statement defines which variables
will be grouped for significance testing. In this case, the
variables are concentration and group, and ANCOVA
assumes that these are co-varying in nature. The contrast
and estimate statements were used to contrast the group
effect, which will yield ∆∆Ct (-0.6848), as well as its stand-
ard error (0.1185) and 95% confidence interval (-0.9262,
-0.4435). The SAS output with both confidence level and
P value is presented in SASOutputs.doc (additional file 3).
Simplified alternatives – T-test and wilcoxon two group 
test
More simplified alternatives can be used to analyze real-
time data with biological replicates for each experiment.
The primary assumption with this approach is that the
additive effect of concentration, gene, and replicate can be
adjusted by subtracting Ct number of target gene from
that of reference gene, which will provide ∆Ct as shown in
Table 2. The ∆Ct for treatment and control can therefore
be subject to simple t-test, which will yield the estimation
of ∆∆Ct.
As a non-parametric alternative to the t-test, a Wilcoxon
two group test can also be used to analyze the two pools
of ∆Ct values. Two of the assumptions for t-test are that
the both groups of ∆Ct will have Gaussian distributions
and they will have equal variances. However, these
assumptions are not valid in many real-time PCR experi-
ments using realistically small sample sizes. Therefore a
distribution-free Wilcoxon test will be a more robust and
appropriate alternative in this case [15].BMC Bioinformatics 2006, 7:85 http://www.biomedcentral.com/1471-2105/7/85
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A SAS program has been developed for both t-test and
Wilcoxon two group test as shown in the attached pro-
gram Program4_TW.sas (additional file 7). The SAS proce-
dures TTEST and UNIVARIATE were used to analyze the
data. The SAS Macro 'moses.sas' [15] in additional file 8
has been employed to derive the confidence levels. The
SAS input file is in additional file 9 and the SAS output for
sample data analysis is available in SASOutput.doc (addi-
tional file 3). Since the estimate of difference derives from
subtracting treatment from control sample, the actual
∆∆Ct should be the inverse of the output estimate.
Comparison of four approaches and data presentation
A comparison of the four approaches is presented in Table
3. Multiple regression and ANCOVA yield exactly the
same result for ∆∆Ct estimation, because both methods
employ the same mathematical approach for parameter
estimation. The t-test provides the same point estimation
of ∆∆Ct, however, the standard error is slightly greater,
which leads to a larger confidence interval. Wilcoxon two
group test provides a slightly smaller estimation of ∆∆Ct.
The highly similar results from the four approaches vali-
dated the models and SAS programs presented. The choice
of the models and programs will depend on the experi-
mental design and the stringency and quality of the exper-
iment. However, the most conservative test, owing to its
nonparametric nature, is the Wilcoxon two group test,
which is distribution-independent.
Data quality control
Many of the current real-time PCR experiments do not
include a standard curve design, nor do they use a method
to estimate the amplification efficiency. We argue here
that real-time PCR data without proper quality controls
are not reliable, since the efficiency of real-time PCR could
have significant impact on the ratio estimation and
dynamic range. For example, if a PCR has a percentage
amplification efficiency (PE) of 0.8 (i.e. PCR product will
increase 20.8 times instead of two times per cycle), a ∆Ct
value of 3 can only be transformed into 5.27 times differ-
ences in ratio instead of 8 times. This problem gets ampli-
fied when the ∆∆Ct or ∆Ct values are larger and the
amplification efficiency is lower, which could lead to
severely skewed interpretations.
We therefore propose two standards for real-time PCR
data quality control according to the model using the SAS
programs presented in this paper. First, experiments with
a serial dilution of template need to be included in order
to estimate the amplification efficiency of each gene with
each sample. Some researchers assume that the amplifica-
tion efficiency for each gene is the same in different sam-
ples because the same primer pair and amplification
Table 2: ∆Ct calculation. The table presents the calculation of ∆Ct, which is derived from subtracting Ct number of reference gene 
from that of the target gene. Con stands for concentration.
Sample Gene Con Ct Sample Gene Con Ct ∆Ct
Control Target 10 23.1102 Control Reference 10 19.7415 3.3687
Control Target 10 22.9003 Control Reference 10 19.494 3.4063
Control Target 10 22.8972 Control Reference 10 19.3906 3.5066
Control Target 2 26.5801 Control Reference 2 21.9838 4.5963
Control Target 2 26.2139 Control Reference 2 22.4435 3.7704
Control Target 2 26.0606 Control Reference 2 22.57 3.4906
Control Target 0.4 28.1125 Control Reference 0.4 24.8109 3.3016
Control Target 0.4 28.1899 Control Reference 0.4 24.4327 3.7572
Control Target 0.4 27.5949 Control Reference 0.4 24.2342 3.3607
Control Target 0.08 30.2772 Control Reference 0.08 26.7319 3.5453
Control Target 0.08 30.4667 Control Reference 0.08 26.8206 3.6461
Control Target 0.08 30.7571 Control Reference 0.08 26.822 3.9351
Treatment Target 10 21.7813 Treatment Reference 10 18.4468 3.3345
Treatment Target 10 21.7564 Treatment Reference 10 18.8227 2.9337
Treatment Target 10 21.641 Treatment Reference 10 18.3061 3.3349
Treatment Target 2 23.7965 Treatment Reference 2 21.2568 2.5397
Treatment Target 2 23.7571 Treatment Reference 2 21.0956 2.6615
Treatment Target 2 23.724 Treatment Reference 2 20.8473 2.8767
Treatment Target 0.4 26.3794 Treatment Reference 0.4 23.2322 3.1472
Treatment Target 0.4 26.2542 Treatment Reference 0.4 22.9577 3.2965
Treatment Target 0.4 25.9621 Treatment Reference 0.4 23.2415 2.7206
Treatment Target 0.08 28.5479 Treatment Reference 0.08 25.4817 3.0662
Treatment Target 0.08 28.3894 Treatment Reference 0.08 25.608 2.7814
Treatment Target 0.08 28.3416 Treatment Reference 0.08 25.5675 2.7741BMC Bioinformatics 2006, 7:85 http://www.biomedcentral.com/1471-2105/7/85
Page 8 of 12
(page number not for citation purposes)
conditions are used. However, we found that sample
effect does have an impact on the amplification efficiency.
In other words, the amplification efficiency could be dif-
ferent for the same gene when amplified from different
cDNA template samples. We therefore consider the exper-
imental design with standard curve for each gene and
sample combination as the optimal. Second, under opti-
mal conditions, if a plot of the Ct number against the log-
arithm (2-based) template amount should yield a slope
not significantly different from -1, which indicates a
nearly 2 amplification efficiency. Even though both effi-
ciency-calibrated model and modified ∆∆Ct model toler-
ates the amplification efficiency lower than 2, it is most
reliable to have all the reaction with amplification effi-
ciency approximating 2 through optimizing primer
choices, amplicon lengths and experimental conditions.
From our experience, maintaining all the amplification
efficiency near 2 is the best way to reach equal amplifica-
tion efficiency among the samples and thus to ensure high
quality data. It is also observed that a near 2 amplification
efficiency can help to expand the dynamic range of ratio
estimation.
P-value, confidence intervals and data presentation
The P-value is an important parameter for significance
level, and confidence intervals help to establish the relia-
ble range for ∆∆Ct estimation. Most of current real-time
PCR publications do not present P-values and confidence
intervals [11-13]. We believe disclosing P-values is impor-
tant when the researchers claim differential expression
between the samples or treatments exists. In the program
we present, all the P-values are derived from testing the
null hypothesis that ∆∆Ct are equal to 0. Therefore, a
small P-value indicates that the ∆∆Ct is significantly dif-
ferent from 0, which demonstrates a significant effect. The
interpretation of a P-value will depend on the experimen-
tal objectives. For example, at P = 0.05 in a treatment ver-
sus control experiment, we can claim that the treatment
has a significant effect; and in a tissue comparison experi-
ment, we can claim that the gene expression is signifi-
cantly different among the tissues.
Some publications present a standard deviation of the
ratio as a meaningful metric. However, we argue here that
the standard deviation of ratio should be derived from the
standard deviation of ∆∆Ct; and the confidence interval of
the ratio should be derived from the confidence interval
of ∆∆Ct. In other words, the point estimation of ratio
should be 2-∆∆Ct and the confidence interval for ratio
should be (2-∆∆CtHCL, 2-∆∆CtLCL). Since Ct is the observed
value from experimental procedures, it should be the sub-
ject of statistical analysis. The practice of performing sta-
tistical analysis at ratio directly is not appropriate. The
presentation of data needs to refer to the ∆∆Ct and subse-
quently the ratio and confidence intervals derived from 2-
∆∆Ct.
Statistical analysis for real-time PCR data with 
amplification efficiency less than 2
As stated before, the PCR amplification efficiency can be
optimized to be approximately 2 with proper amplifica-
tion primers, RNA quality, and cDNA synthesis protocol.
Recent advancements in real-time PCR primer design have
allowed easier experimental optimization [16,17]. How-
ever, less than ideal real-time PCR data can occur regard-
less the stringent control of experimental conditions.
There are three scenarios for suboptimal real-time PCR
data. In the first scenario, all of the PCR reactions have the
same amplification efficiency, yet the efficiency differs
from 2. In the second scenario, the PCR amplification effi-
ciency differs by gene only. In other words, the amplifica-
tion efficiency is the same for the same gene in all the
biological samples; however, the amplification efficiency
varies among the different genes. In the third scenario, the
PCR amplification efficiency differs both by gene and by
sample. We considered the data in the third scenario as
unacceptable as many others have reported [10,18]. In
any of these scenarios, the adjusted ∆∆Ct can be derived
from the ANCOVA model by including the PE in the 'esti-
mate' and 'contrast' statement of the SAS program.
Several approaches have been developed to calculate the
amplification efficiency in the low quality data. One of
such approach is so called 'dynamic data analysis', in
which the fluorescence history of a PCR reaction is
employed to calculate the amplification efficiency
[19,20]. The advantage of the approach lies in the capacity
to analyze low quality data and the economy in cost by
avoiding the standard curve. However, due to the mathe-
Table 3: The comparison of four approaches. The table listed ∆∆Ct, standard error, P-value and confidence interval derived from the 
four methods presented in the article. Neither SAS package nor the macro used provides the standard error for Wilcoxon two group 
test. We consider confidence interval to be sufficient for further data transformation.
Model ∆∆Ct Standard Error P-Value Confidence Interval
Multiple Regression -0.6848 0.1185 < 0.0001 (-0.4435, -0.9262)
ANCOVA -0.6848 0.1185 < 0.0001 (-0.4435, -0.9262)
t-test -0.6848 0.1303 < 0.0001 (-0.4147, -0.955)
Wilcoxon Test -0.6354 < 0.0001 (-0.4227, -0.8805)BMC Bioinformatics 2006, 7:85 http://www.biomedcentral.com/1471-2105/7/85
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matical complexity and the reliability controversy, this
method is not as widely applied as the traditional stand-
ard curve method [10,16,18]. In our method, a standard
curve already exists and can be used to derive amplifica-
tion efficiency (E). Considering the simple linear regres-
sion model in Equation 3, if Xlcon represents 10 based
logarithm transformed concentration, the amplification
efficiency (E) is 10-(1/slope) or   according  to
Ramussen 2001 and Pfaffl 2001 [7,21]. In our model, Xlcon
represents the 2 based logarithm transformed concentra-
tion, the amplification efficiency (E) therefore is 2-(1/slope)
or  , where the PE can be represented as -(1/
βcon).
In the first scenario discussed above, all PCR amplifica-
tion have the same efficiency, but the efficiency is not
equal to 1. Then the ratio of gene expression can be repre-
sented in the following equation.
whereas PE = -(1/βcon), and ∆∆Ctadjust = PE*∆∆Ct
In the Equation 6, βcon is the pooled slope of the plot with
Ct against logarithm 2 based concentration. The βcon can
be calculated with a correlation function in SAS as shown
in Program5_LowQualityData.sas in Additional file 10. In
the second scenario, the amplification efficiency differs by
gene only. According to Equation 1, we have the following
equation, in which the β0 is the pooled slope of the plot of
Ct against log2 (concentration) for each gene.
whereas  PEtarget  = -(1/βconTarget),  PEcontrol = -(1/βconControl),
and ∆∆Ctadjust = PEtarget*∆Cttarget-PEcontrol*∆Ctcontrol
In the Equation 7, βconTarget and βconControl are the pooled
slope for the plot of Ct against logarithm 2 based concen-
tration for target gene and reference gene respectively. The
slopes can be calculated by the
Program5_LowQualityData.sas (additional file 10). The
∆∆Ctadjust can be calculated with the same program. Theo-
retically, an equation can also be derived for the third sce-
nario when PCR amplification efficiency differs both by
gene and by sample. However, in actual application, we
don't consider the data in the third scenario as acceptable
due to the significant variation of the amplification effi-
ciency [10,18].
The Program5_LowQuatilityData.sas in additional file 10
provides the solution to derive the adjusted ∆∆Ct in the
first and second scenarios. A data set with amplification
efficiency different by gene is provided in LowQuality-
Data.txt in additional file 11 to illustrate the use of the SAS
program. The data set is of lower quality mainly because
of the limited number of replicates involved in the exper-
iment. Four steps are involved in calculating the ∆∆Ctadjust.
The first step is to perform the data quality control test as
shown in Methods. From the SAS output, we can conclude
that the LowQualityData dataset does not meet the
requirements for 2-∆∆Ct method, since one group of PCR
has amplification efficiency significantly different from 1
as shown in the data quality control for LowQualityData
dataset part of SASOutput.doc (additional file 3).
The second step is to test the equal PCR efficiency (or
slope) by observing the Type III sums of squares for lcon
and class interaction. A low p value will indicate the inter-
action of different groups of PCR (class) with logarithm
transformed concentration, which in turn indicates the
unequal slope among different groups of PCR. If all PCR
amplification efficiency are equal, then the pooled ampli-
fication efficiency can be calculated and integrate into the
SAS program for ∆∆Ctadjust calculation. In this set of data,
the Type III sums of squares has a p value smaller than
0.05, and the amplification efficiency are not equal for all
PCRs. Tests of equal slopes are then performed for each
gene to decide whether PCR amplification efficiency is the
same for each gene. For either gene, the amplification effi-
ciency is not significantly different with an α of 0.05. All
of the Type III sums of squares outputs can be found in
SASOutput.doc (additional file 3).
The next step is to calculate the pooled slope (βcon) for
each gene to derive the percentage amplification efficiency
(PE = -(1/βcon)) for each gene. The pooled slopes are
derived based on the correlation between Ct and loga-
rithm 2 based concentrations. The βcons for the two genes
are -1.0813 and -1.0137 respectively as shown in SASOut-
put.doc (additional file 3) for the amplification efficiency
calculation of LowQualityData dataset. With the βcon, -(1/
βcon) or PE can be calculated for each gene as 0.925 and
0.987 respectively. The ∆∆Ctadjust can then be computed
with PEs substituting the 1 for each gene in the 'estimate'
and 'contrast' statement. The SAS program is as follows in
additional file 10.
Title 2 'Calculate the deltadeltaCt with Adjusted effi-
ciency';
PROC MIXED data=TR2 Order=Data;
CLASS Class Con;
10 1 −(/ ) βcon
2 1 −(/ ) βcon
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te t
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et t et
conControl control
te t
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∆
∆
∆
2
2
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∗ =
β
t tP E C t t et control control Equation
arg ) −∗ ∆  7BMC Bioinformatics 2006, 7:85 http://www.biomedcentral.com/1471-2105/7/85
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MODEL Ct = Con Class Con*Class/SOLUTION NOINT;
Contrast 'Intercepts' Class 0.925 -0.925 -0.987 0.987;
Estimate 'Intercepts' Class 0.925 -0.925 -0.987 0.987/cl;
Run;
The SAS output for the analysis is in SASOutput.doc
(additional file 3). The ∆∆Ctadjust is therefore -1.0901 and
the change is significant since p value is very small. The
ratio can be represented as discussed in the standard ∆∆Ct
method. The point estimation of the ratio in this example
is 2.129, and the 95% confidence interval is (1.926,
2.353).
Overall, in the less optimized PCR reactions, statistical
analysis is not only complicated but also compromised
for precision and efficiency. Therefore caution should be
exercised when performing statistical analysis with the
low quality real-time PCR data, which may easily intro-
duce error due to the efficiency adjustment [10,18].
Conclusion
In this report, we presented four models of statistical anal-
ysis of real-time PCR data and one procedure for data
quality control. SAS programs were developed for all the
applications and a sample set of data was analyzed. The
analyses with different models and programs yielded the
same estimation of ∆∆Ct and similar confidence intervals.
The data quality control and analysis procedures will help
to establish robust systems to study the relative gene
expression with real-time PCR.
Methods
Plant material, RNA extraction, real-time PCR and sample 
data set
The sample data set (Table 1) used for the analysis came
from the experiment described below. Arabidopsis thaliana
(Col1) plants were grown in the growth chamber at 23°C
with 14 hours of light for four weeks. Total RNA was iso-
lated with RNeasy Plant Mini Kit (Qiagen, Inc.) from
methyl-jasmonate treated Arabidopsis, alamethecin treated
Arabidopsis and control plants, and DNA contamination
was removed with an on-column DNase (Qiagen, Inc.)
treatment. One microgram of total RNA was synthesized
into first strand cDNA in a 20 µL reaction using iScript
cDNA synthesis kit (BioRad Laboratories). cDNA was
then diluted into 10 ng/µL, 2 ng/µL, 0.4 ng/µL and 0.08
ng/µL concentration series. Three replicates of real-time
PCR experiments were performed for each concentration
using an ABI 7000 Sequence Detection System from
Applied Biosystems (Applied Biosystems). Ubiquitin was
used as the reference gene, and the primer sequences for
Arabidopsis  ubiquitin gene were CACACTCCACTT-
GGTCTTGCG (F) and TGGTCTTTCCGGTGAGAGTCT-
TCA (R). The primers for target gene (MT_7) were
designed by Primer Express software (Applied Biosys-
tems) and the sequences were CCGCGGTACAAACCT-
TAATT (F) and TGGAACTCGATTCCCTCAAT (R). MT-7
gene is the Arabidopsis thaliana gene At3g44860 encoding
a protein with high catalytic specificity for farnesoic acid
[22]. Primer titration and dissociation experiments were
performed so that no primer dimmers or false amplicons
will interfere with the result. After the real-time PCR
experiment, Ct number was extracted for both reference
gene and target gene with auto baseline and manual
threshold.
Real-time PCR experimental design, data output, 
transformation, and programming
A main limitation of efficiency calibrated method and
∆∆Ct method is that only one set of cDNA samples are
employed to determine the amplification efficiency. It
was assumed that the same amplification efficiency could
be applied to other cDNA samples as long as the primers
and amplification conditions are the same. However,
amplification efficiency not only depends on the primer
characteristics, but also varies among different cDNA sam-
ples. Using a standard curve for only one set of tested sam-
ples to derive the amplification efficiency might overlook
the error introduced by sample differences. In our experi-
mental design, we have performed standard curve experi-
ments with four concentrations of three replicates for all
samples and genes involved. The ∆∆Ct will derive from
the standard curves only, and the data quality is examined
for each gene and sample combination. The analysis of
two samples is presented in the paper as an example. A
minimal of PCRs of two replicates in three concentrations
will be required for each sample. Even though more effort
is required, the data is more reliable out of stringent data
quality control and data analysis based on statistical mod-
els.
The output dataset included Ct number, gene name, sam-
ple name, concentration and replicate. We used Micro-
soft® Excel to open the exported Ct file from an ABI 7000
sequence analysis system and then to transform data into
a tab delimited text file for SAS processing. The sample
data set is shown in Table 1.
All programs were developed with SAS 9.1 (SAS Institute).
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